Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying moderate facial acne in patients with darker skin tones, specifically Fitzpatrick skin types IV to VI. The study aims to compare the effects of oral isotretinoin as a first-line treatment versus the current standard care, which includes oral antibiotics and topical creams, focusing on the severity of acne-related pigmentation after six months. Acne affects about 9% of the global population and can impact quality of life, especially in people of color who often experience pigmentation issues linked to acne. Participants will be assigned to one of two groups. One group receives oral isotretinoin starting at 0.5 mgkgday, with possible dose adjustments based on tolerance and effectiveness over six months. The other group receives standard care, consisting of topical tretinoin or adapalene cream daily combined with doxycycline or lymecycline 100 mgday for three months, followed by assessment and possible continuation of topical treatment only. Participants in the isotretinoin group are followed monthly, while those in the standard care group have visits at 3 and 6 months. During the study, participants will be monitored for acne-related pigmentation severity, quality of life, and adverse events over six months. Assessments include clinical evaluations and self-photography using a smartphone with adequate camera resolution. Safety monitoring involves checking blood tests and pregnancy status for women of childbearing potential. The trial is randomized, open-label, and aims to enroll 420 participants aged 13 to 30 years with moderate acne and skin types IV to VI.